Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4403301000168119 | calcium carbonate 325 mg / 10 mL + sodium alginate 500 mg / 10 mL + sodium bicarbonate 213 mg / 10 mL oral liquid, 100 mL (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4403311000168116 | sodium alginate 500 mg/10 mL + sodium bicarbonate 213 mg/10 mL + calcium carbonate 325 mg/10 mL oral liquid, 100 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sodium alginate 500 mg/10 mL + sodium bicarbonate 213 mg/10 mL + calcium carbonate 325 mg/10 mL oral liquid, 100 mL | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| sodium alginate 500 mg/10 mL + sodium bicarbonate 213 mg/10 mL + calcium carbonate 325 mg/10 mL oral liquid, 100 mL | has MPUU | sodium alginate 500 mg/10 mL + sodium bicarbonate 213 mg/10 mL + calcium carbonate 325 mg/10 mL oral liquid | true | Inferred relationship | Some | 496300649 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gaviscon Dual Action Peppermint oral liquid, 100 mL | Is a | True | sodium alginate 500 mg/10 mL + sodium bicarbonate 213 mg/10 mL + calcium carbonate 325 mg/10 mL oral liquid, 100 mL | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR